Transcription Factor Decoy (TFD) as a novel approach for the control of osteoclastic resorption

Prog Orthod. 2005;6(2):238-47.
[Article in English, Italian]
No abstract available

Publication types

  • Review

MeSH terms

  • Alveolar Bone Loss / prevention & control*
  • Animals
  • Apoptosis / physiology
  • Apoptosis Regulatory Proteins / therapeutic use
  • Carrier Proteins / physiology
  • Carrier Proteins / therapeutic use
  • Glycoproteins / physiology
  • Glycoproteins / therapeutic use
  • Humans
  • Mandibular Diseases / prevention & control*
  • Maxillary Diseases / prevention & control*
  • Membrane Glycoproteins / physiology
  • Membrane Glycoproteins / therapeutic use
  • Mice
  • NF-kappa B / physiology
  • NF-kappa B / therapeutic use*
  • Osteoclasts / physiology*
  • Osteoprotegerin
  • RANK Ligand
  • Receptor Activator of Nuclear Factor-kappa B
  • Receptors, Cytoplasmic and Nuclear / physiology
  • Receptors, Cytoplasmic and Nuclear / therapeutic use
  • Receptors, Tumor Necrosis Factor / physiology
  • Receptors, Tumor Necrosis Factor / therapeutic use
  • Repressor Proteins / therapeutic use
  • Transcription Factors / physiology
  • Transcription Factors / therapeutic use

Substances

  • AATF protein, human
  • Apoptosis Regulatory Proteins
  • Carrier Proteins
  • Glycoproteins
  • Membrane Glycoproteins
  • NF-kappa B
  • Osteoprotegerin
  • RANK Ligand
  • Receptor Activator of Nuclear Factor-kappa B
  • Receptors, Cytoplasmic and Nuclear
  • Receptors, Tumor Necrosis Factor
  • Repressor Proteins
  • TNFRSF11A protein, human
  • TNFRSF11B protein, human
  • TNFSF11 protein, human
  • Tnfrsf11a protein, mouse
  • Tnfrsf11b protein, mouse
  • Tnfsf11 protein, mouse
  • Transcription Factors